Boston Scientific (BSX) Gains From Acquisitions, New Launches - Yahoo Finance

Boston Scientific BSX is gaining traction in emerging markets. Also, accretive acquisitions and significant progress in the company’s restructuring initiatives buoy optimism. The stock carries a ... Read More

Boston Scientific (BSX) Gains From New Buyouts, Cost Woes Stay - Yahoo Finance

Boston Scientific BSX is gaining traction in emerging markets. Accretive acquisitions also buoy optimism. Yet, unfavorable currency movement and a tough competitive landscape in the large medical ... Read More

Boston Scientific (BSX) Gains from New Buyouts, FX Issue Ails

Boston Scientific Corporation BSX has been gaining from its slew of strategic acquisitions and product launches. However, mounting operating expenses and foreign exchange headwinds raise apprehension. Read More

Boston Scientific Stock Gains From Market Expansion, Innovation - MSN

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2 (Buy ... Read More

Boston Scientific (BSX) New Buyouts Aid Amid COVID Resurgence

Boston Scientific Corporation’s BSX recent acquisitions have added various products with immense potential to its portfolio. However, unfavorable currency movement and product recalls have been ... Read More

What’s Next For Boston Scientific Stock After Outperforming During The 2022 Inflation Shock?

BSX Fundamentals Over Recent Years. Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the ... Read More

Boston Scientific (BSX) Poised for Growth: A Buy Recommendation Amid Strong Q1 Performance and Strategic Acquisitions - Markets Insider

Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report) and increased the price target to $82.00 from $72.00. Larry Biegelsen has given his ... Read More

What’s Next For Boston Scientific Stock After 5% Gains In A Week?

BSX stock has seen extremely strong gains of 55% from levels of $35 in early January 2021 to around $55 now, vs. an increase of about 15% for the S&P 500 over this roughly 3-year period. Read More

BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain? - MSN

Following the announcement, shares of Boston Scientific lost 1.2% to $82.52 yesterday. However, the company continues to gain a high level of synergies from its continuous development within the ... Read More

Boston Scientific (BSX) Gains From Acquisitions, New Launches

Boston Scientific BSX is gaining traction in emerging markets. Also, accretive acquisitions and significant progress in the company’s restructuring initiatives buoy optimism. The stock carries a ... Read More